| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |